Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Print   Email Upcoming Event Mar 16, 2010 12:30 PM PT The ROTH 22nd Annual OC Growth Stock Conference Listen to webcast Additional Information Remind me Please sign up for email alert notification. Ritz-Carlton Dana Point, CA Archived Events Mar 8, 2010 4:45 PM ET The Cowen Healthcare Conference Listen to webcast Additional Information Marriott Copley Place Hotel Boston, MA Mar 3, 2010 8:30 AM ET Medivation Phase 3 Dimebon Results Conference Call Listen to webcast Feb 9, 2010 11:30 AM ET 12th Annual BIO CEO & Investor Conference Speaker: Dr. David T. Hung, President, Chief Executive Officer, Director Listen to webcast Oct 27, 2009 8:30 AM ET Medivation Conference Call to Discuss Partnering Plans for MDV3100 Listen to webcast Feb 25, 2009 4:30 PM ET Medivation Prostate Cancer Conference Call and Slide Presentation Listen to webcast Slide Presentation 534.7 KB   ASCO 2009 Genitourinary Cancers Symposium Phase 1-2 Study of MDV3100 in Castration-Resistant Prostate Cancer 373.5 KB   = add file to Briefcase